Private equity firm Altus Capital Partners has inked a deal to acquire MGC Diagnostics Corp in a $50.3 million deal. In the deal, Altus will pay $11.03 per share for each share of MGCD, equalling out to approximately $50.3 million, representing a 44% premium on its January 24 closing price of $7.65. “We look forward […]